Search & Filter

A non-peer-reviewed study funded by abortion pill investors and conducted at California and other states' abortion facilities found significant gaps in patients' understanding of abortion pill risks despite receiving a required Patient Agreement Form (PAF). The study urges the FDA to remove the PAF requirement to streamline abortion pill provision, although nearly 10% of participants did not know when to seek emergency care, highlighting safety concerns in California and other states.

An estimated 6,000 pharmacies nationwide dispense the abortion pill, with California having 287 Danco-certified and 34 GenBioPro-certified pharmacies, plus 71 mail-order pharmacies certified to dispense the drug. California also has the highest number of certified abortion pill prescribers at 2,061, reflecting significant distribution and prescribing activity within the state.

Researchers at UC San Francisco's ANSIRH have introduced a prototype called MiMi, an over-the-counter abortion pill kit containing mifepristone and misoprostol, aiming to envision a future where medication abortion is accessible without a prescription. The prototype promotes easier access to abortion pills, despite ongoing FDA safety reviews and legal challenges, reflecting efforts within California to expand abortion availability.